News | July 29, 2023
AiMeD expresses dismay over FICCI’s ‘Un-Make in India’ drive
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
CARA is a data and content management platform that helps companies in regulated industries such as finance, energy, and manufacturing transform their complex business processes
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
There is a pressing need for continuous improvement and innovation in food safety systems to keep pace with emerging food trends and habits
The agency issued a Form 483 with 6 observations for Drug Substance, Drug Product units and Quality Control laboratories
Aurobindo will respond to the US FDA within the stipulated timelines
Good momentum in commercial CDMO business
Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis
Subscribe To Our Newsletter & Stay Updated
